Fig. 3.

Reduced BCL-6 expression in the absence of MOZ. (A and B) Representative plots of BCL-6 expression versus Fas (arrow; A) in CD19⁺IgD^lo cells, and BCL-6 expression in NP⁺Fas^hiCD19⁺IgD^lo cells (B), day 7 postimmunization. (C) Geometric mean fluorescence intensity (GMFI) of BCL-6 in NP⁺Fas^hiCD19⁺IgD^lo cells in Mb-1^Cre/+ (black bars) and Moz^fl/flMb-1^Cre/+ (white bars). Data are combined from three (day 7) and two (day 13) experiments; n = 5–10 per genotype. Error bars indicate ± SEM. **P < 0.01.